vs

Side-by-side financial comparison of Akso Health Group (AHG) and FISERV INC (FISV). Click either name above to swap in a different company.

FISERV INC is the larger business by last-quarter revenue ($5.3B vs $7.0M, roughly 754.8× Akso Health Group). FISERV INC runs the higher net margin — 15.3% vs -18.6%, a 33.9% gap on every dollar of revenue.

Akso Health Group is a global healthcare enterprise specializing in the R&D, production, and distribution of generic pharmaceuticals, over-the-counter wellness products, and medical devices. It primarily serves markets in China, Southeast Asia, and North America, with core business segments covering drug manufacturing, medical supply chains, and community healthcare services.

Fiserv, Inc. is an American multinational financial technology company headquartered in Milwaukee, Wisconsin. The company processes debit and credit card transactions, loyalty programs, loans, electronic bill pay, wires and ACH transfers, check deposits, and ATM transactions on behalf of banking institutions. The company also produces debit and credit cards and point of sale terminals.

AHG vs FISV — Head-to-Head

Bigger by revenue
FISV
FISV
754.8× larger
FISV
$5.3B
$7.0M
AHG
Higher net margin
FISV
FISV
33.9% more per $
FISV
15.3%
-18.6%
AHG

Income Statement — Q2 2026 vs Q4 2025

Metric
AHG
AHG
FISV
FISV
Revenue
$7.0M
$5.3B
Net Profit
$-1.3M
$811.0M
Gross Margin
8.9%
Operating Margin
-20.5%
24.4%
Net Margin
-18.6%
15.3%
Revenue YoY
0.6%
Net Profit YoY
-13.5%
EPS (diluted)
$1.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHG
AHG
FISV
FISV
Q4 25
$5.3B
Q3 25
$7.0M
$5.3B
Q2 25
$5.5B
Q1 25
$5.1B
Q4 24
$5.3B
Q3 24
$5.2B
Q2 24
$5.1B
Q1 24
$4.9B
Net Profit
AHG
AHG
FISV
FISV
Q4 25
$811.0M
Q3 25
$-1.3M
$792.0M
Q2 25
$1.0B
Q1 25
$851.0M
Q4 24
$938.0M
Q3 24
$564.0M
Q2 24
$894.0M
Q1 24
$735.0M
Gross Margin
AHG
AHG
FISV
FISV
Q4 25
Q3 25
8.9%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
AHG
AHG
FISV
FISV
Q4 25
24.4%
Q3 25
-20.5%
27.3%
Q2 25
30.7%
Q1 25
27.2%
Q4 24
31.8%
Q3 24
30.7%
Q2 24
28.0%
Q1 24
24.2%
Net Margin
AHG
AHG
FISV
FISV
Q4 25
15.3%
Q3 25
-18.6%
15.0%
Q2 25
18.6%
Q1 25
16.6%
Q4 24
17.9%
Q3 24
10.8%
Q2 24
17.5%
Q1 24
15.1%
EPS (diluted)
AHG
AHG
FISV
FISV
Q4 25
$1.51
Q3 25
$1.46
Q2 25
$1.86
Q1 25
$1.51
Q4 24
$1.63
Q3 24
$0.98
Q2 24
$1.53
Q1 24
$1.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHG
AHG
FISV
FISV
Cash + ST InvestmentsLiquidity on hand
$11.1M
$798.0M
Total DebtLower is stronger
$27.8B
Stockholders' EquityBook value
$198.3M
$25.8B
Total Assets
$212.0M
$80.1B
Debt / EquityLower = less leverage
1.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHG
AHG
FISV
FISV
Q4 25
$798.0M
Q3 25
$11.1M
$1.1B
Q2 25
$999.0M
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Total Debt
AHG
AHG
FISV
FISV
Q4 25
$27.8B
Q3 25
$28.9B
Q2 25
$28.1B
Q1 25
$27.0B
Q4 24
$23.7B
Q3 24
$24.1B
Q2 24
$24.4B
Q1 24
$23.8B
Stockholders' Equity
AHG
AHG
FISV
FISV
Q4 25
$25.8B
Q3 25
$198.3M
$25.1B
Q2 25
$25.2B
Q1 25
$25.9B
Q4 24
$27.1B
Q3 24
$27.8B
Q2 24
$28.2B
Q1 24
$28.8B
Total Assets
AHG
AHG
FISV
FISV
Q4 25
$80.1B
Q3 25
$212.0M
$79.4B
Q2 25
$81.5B
Q1 25
$80.4B
Q4 24
$77.2B
Q3 24
$79.8B
Q2 24
$93.4B
Q1 24
$92.7B
Debt / Equity
AHG
AHG
FISV
FISV
Q4 25
1.08×
Q3 25
1.15×
Q2 25
1.11×
Q1 25
1.04×
Q4 24
0.88×
Q3 24
0.87×
Q2 24
0.87×
Q1 24
0.82×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHG
AHG
FISV
FISV
Operating Cash FlowLast quarter
$1.2M
$1.9B
Free Cash FlowOCF − Capex
$1.5B
FCF MarginFCF / Revenue
28.4%
Capex IntensityCapex / Revenue
8.4%
Cash ConversionOCF / Net Profit
2.40×
TTM Free Cash FlowTrailing 4 quarters
$4.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHG
AHG
FISV
FISV
Q4 25
$1.9B
Q3 25
$1.2M
$1.8B
Q2 25
$1.7B
Q1 25
$648.0M
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$1.3B
Q1 24
$831.0M
Free Cash Flow
AHG
AHG
FISV
FISV
Q4 25
$1.5B
Q3 25
$1.3B
Q2 25
$1.2B
Q1 25
$313.0M
Q4 24
$1.8B
Q3 24
$1.8B
Q2 24
$993.0M
Q1 24
$411.0M
FCF Margin
AHG
AHG
FISV
FISV
Q4 25
28.4%
Q3 25
24.7%
Q2 25
21.5%
Q1 25
6.1%
Q4 24
34.7%
Q3 24
35.2%
Q2 24
19.4%
Q1 24
8.4%
Capex Intensity
AHG
AHG
FISV
FISV
Q4 25
8.4%
Q3 25
9.6%
Q2 25
8.7%
Q1 25
6.5%
Q4 24
7.6%
Q3 24
7.7%
Q2 24
6.8%
Q1 24
8.6%
Cash Conversion
AHG
AHG
FISV
FISV
Q4 25
2.40×
Q3 25
2.28×
Q2 25
1.62×
Q1 25
0.76×
Q4 24
2.37×
Q3 24
3.97×
Q2 24
1.50×
Q1 24
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHG
AHG

Segment breakdown not available.

FISV
FISV

Small Business$1.7B32%
Products$1.0B19%
Digital Payments$960.0M18%
Issuing$792.0M15%
Enterprise$587.0M11%
Processing$265.0M5%
Affiliated Entity$18.0M0%

Related Comparisons